
You are now leaving www.astellas.com/us. The website you are linking to is neither owned nor controlled by Astellas.
Astellas is not responsible for the content or services on this site.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
The site uses cookies to provide you with a more responsive and personalized service and to analyze site traffic. By using this site, you accept our use of cookies as described in our privacy policy. Please read our privacy policy for more information on the cookies we use, the processing of your personal data and how to delete or block the use of cookies.
Health is Our Passion and Priority
Astellas Pharma US is focused on providing safe and effective products that improve people's lives. We are committed to making a difference for our patients today and providing them with a brighter future tomorrow.
This commitment extends to providing resources for our patients and their physicians and caregivers that help them throughout the life cycle of their condition and beyond.
Below is a list of Astellas' products marketed in the U.S. This information is intended for U.S. residents only.
View Astellas products for the global market on our global website.
Lexiscan® (regadenoson) injection
ASTAGRAF XL® (tacrolimus extended-release capsules)
Prograf® (tacrolimus) capsules, granules and injection
AmBisome® (amphotericin B) liposome for injection
CRESEMBA® (isavuconazonium sulfate)
MYCAMINE® (micafungin for injection) for intravenous use
XTANDI® (enzalutamide) capsules
XOSPATA® (gilteritinib) tablets
PADCEV® (enfortumab vedotin-ejfv)
Myrbetriq® (mirabegron) extended-release tablets
VESIcare® (solifenacin succinate) tablets
VESIcare LSTM (solifenacin succinate) oral suspension
This information is intended for U.S. residents only.
All trademarks are Astellas’ except:
AmBisome is a registered trademark of Gilead Sciences, Inc.
1 Astellas Way, Northbrook, IL 60062, an affiliate of Astellas Pharma US, Inc.